Infliximab therapy intensification upon loss of response: Is there an optimal trough level?

Bella Ungar*, Zohar Ben-Shatach, Gal Ben-Haim, Miri Yavzori, Orit Picard, Ella Fudim, Uri Kopylov, Pauline Veyrard, Émilie Del Tedesco, Stephane Paul, Rami Eliakim, Shomron Ben-Horin, Xavier Roblin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Infliximab therapy intensification upon loss of response: Is there an optimal trough level?'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology